← Back to search

ACCELEVIR DIAGNOSTICS LLC

BALTIMORE, MD, 21202

WOSB· Self-reported in SAM

Prime contracting experience

2 records from government sources. Past participation is not evidence of current teaming interest.

RoleAgencyDescriptionVehicleObligatedAction datePeriod
Prime
Department of Health and Human Services
National Institutes of Health
PROVIRAL SEQUENCING DRIVEN DEVELOPMENT OF ENHANCED IPDAV2 WITH GLOBAL HIV-1 GROUP M COVERAGE TO SUPPORT WORLDWIDE CURE AND CLINICAL TRIALS—$2,000,000Jun 5, 2023Jun 1, 2023 – May 31, 2025
Prime
Department of Health and Human Services
National Institutes of Health
THE OBJECTIVE OF THIS CONTRACT IS TO ADAPT THE IPDA FOR THE MEASUREMENT OF LATENT HIV-1 FOR INDIVIDUALS WITH HIV-1 VIRAL GENETIC SUBTYPE CRF-1_AE.—$299,975Feb 14, 2022Jun 1, 2020 – May 31, 2022

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Agencies supported

  • Department of Health and Human ServicesGov-sourced

Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.

ACCELEVIR DIAGNOSTICS LLC – Baltimore, MD | UEI F6SKM7YHCUS7 | FedSub